Notably, treating the CEP55 KO tumor with anti-PD1 significantly reduced tumor volume compared to the control tumor treated with anti-PD1 and the CEP55 KO tumor treated with IgG2b isotype (Figure 5D,E). Here, CEP55 is linked to neoplasm.